C-MER Medical Holdings Limited

SEHK:3309 Voorraadrapport

Marktkapitalisatie: HK$2.9b

C-MER Medical Holdings Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Dennis Lam

Algemeen directeur

HK$6.0m

Totale compensatie

Percentage CEO-salaris95.7%
Dienstverband CEOno data
Eigendom CEO0.9%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur5.5yrs

Recente managementupdates

Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being

May 21
Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being

Recent updates

Is C-MER Medical Holdings (HKG:3309) A Risky Investment?

Oct 18
Is C-MER Medical Holdings (HKG:3309) A Risky Investment?

Not Many Are Piling Into C-MER Medical Holdings Limited (HKG:3309) Stock Yet As It Plummets 27%

Sep 04
Not Many Are Piling Into C-MER Medical Holdings Limited (HKG:3309) Stock Yet As It Plummets 27%

Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being

May 21
Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being

C-MER Eye Care Holdings' (HKG:3309) Earnings May Just Be The Starting Point

Apr 29
C-MER Eye Care Holdings' (HKG:3309) Earnings May Just Be The Starting Point

C-MER Eye Care Holdings Limited's (HKG:3309) 26% Share Price Plunge Could Signal Some Risk

Feb 02
C-MER Eye Care Holdings Limited's (HKG:3309) 26% Share Price Plunge Could Signal Some Risk

C-MER Eye Care Holdings (HKG:3309) Might Be Having Difficulty Using Its Capital Effectively

Jan 17
C-MER Eye Care Holdings (HKG:3309) Might Be Having Difficulty Using Its Capital Effectively

A Look At The Intrinsic Value Of C-MER Eye Care Holdings Limited (HKG:3309)

Apr 24
A Look At The Intrinsic Value Of C-MER Eye Care Holdings Limited (HKG:3309)

Capital Allocation Trends At C-MER Eye Care Holdings (HKG:3309) Aren't Ideal

Dec 04
Capital Allocation Trends At C-MER Eye Care Holdings (HKG:3309) Aren't Ideal

Is C-MER Eye Care Holdings (HKG:3309) A Risky Investment?

Sep 22
Is C-MER Eye Care Holdings (HKG:3309) A Risky Investment?

Update: C-MER Eye Care Holdings (HKG:3309) Stock Gained 25% In The Last Year

Dec 07
Update: C-MER Eye Care Holdings (HKG:3309) Stock Gained 25% In The Last Year

Analyse CEO-vergoeding

Hoe is Dennis Lam's beloning veranderd ten opzichte van C-MER Medical Holdings's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

HK$63m

Mar 31 2024n/an/a

HK$63m

Dec 31 2023HK$6mHK$6m

HK$62m

Sep 30 2023n/an/a

HK$28m

Jun 30 2023n/an/a

-HK$7m

Mar 31 2023n/an/a

-HK$14m

Dec 31 2022HK$6mHK$6m

-HK$22m

Sep 30 2022n/an/a

HK$545k

Jun 30 2022n/an/a

HK$23m

Mar 31 2022n/an/a

HK$22m

Dec 31 2021HK$6mHK$6m

HK$22m

Sep 30 2021n/an/a

HK$25m

Jun 30 2021n/an/a

HK$28m

Mar 31 2021n/an/a

HK$11m

Dec 31 2020HK$4mHK$4m

-HK$6m

Sep 30 2020n/an/a

-HK$10m

Jun 30 2020n/an/a

-HK$13m

Mar 31 2020n/an/a

HK$14m

Dec 31 2019HK$1mHK$1m

HK$41m

Sep 30 2019n/an/a

HK$53m

Jun 30 2019n/an/a

HK$64m

Mar 31 2019n/an/a

HK$53m

Dec 31 2018HK$1mHK$1m

HK$43m

Sep 30 2018n/an/a

HK$35m

Jun 30 2018n/an/a

HK$27m

Mar 31 2018n/an/a

HK$31m

Dec 31 2017HK$4mHK$3m

HK$40m

Compensatie versus markt: De totale vergoeding ($USD 774.23K ) Dennis } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 398.33K ).

Compensatie versus inkomsten: De vergoeding van Dennis is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Dennis Lam (64 yo)

no data

Tenure

HK$6,018,000

Compensatie

Dr. Shun Chiu Lam, JP, also known as Dennis, serves as Chairman and Chief Executive Officer of C-MER Medical Holdings Limited (formerly known as C-MER Eye Care Holdings Limited). Dr. Lam is also a director...


Bestuursleden

NaamPositieTenureCompensatieEigendom
Shun Chiu Lam
Chairman & CEOno dataHK$6.02m0.94%
HK$ 27.0m
Xiaoting Li
Executive Director7.4yrsHK$3.81mgeen gegevens
Yau Wing Lee
Head of Hong Kong Operation & Executive Director7.4yrsHK$240.00k1.08%
HK$ 30.8m
Chiu Cheung Ma
Independent Non-Executive Director6.9yrsHK$240.00kgeen gegevens
Pak-kuen Auyeung
Independent Vice Chairman of the Board4yrsHK$759.00k0.024%
HK$ 699.1k
Ke Yin
Independent Non-Executive Director1.3yrsHK$120.00kgeen gegevens
Shu Kwan Ip
Independent Non-Executive Director4yrsHK$240.00kgeen gegevens

5.5yrs

Gemiddelde duur

64yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 3309 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.5 jaar).